Displaying 1 - 7 of 7 for Hematology
  • MOHEL Study (H-8701)
    • Subjects are being asked to participate in this study because treatment of their disease requires them to receive a stem cell transplant.
  • Prevention of Graft-versus-Host Disease Study (H-36264)
    • The purpose of this study is to compare calcineurin inhibitor (CNI)-free strategies for graft-versus-host disease (GVHD) prophylaxis to standard tacrolimus and methotrexate (Tac/Mtx) in patients with hematologic malignancies.
  • Primary Haemophagocytic Lymphohistiocytosis Study (H-33362)
    • The purpose of this study is to assess the safety, tolerability and efficacy of a new drug aimed at controlling disease activity in patients diagnosed with primary haemophagocytic lymphohistiocytosis.
  • REMAIN Study (H-40203)
    • This trial studies how well nivolumab works in eliminating any remaining cancer cells and preventing cancer from returning in patients with acute myeloid leukemia who had a decrease in or disappearance of signs of cancer after receiving chemotherapy.
  • Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome (H-36160)
    • The purpose of this study is to investigate the effects of sertraline in people with low-risk myelodysplastic syndrome (MDS).
  • Sickle Cell Disease (H-39444)
    • The purpose of this study is to compare survival and sickle related outcomes in adolescents and young adults with severe sickle cell disease after bone marrow transplantation and standard of care.
  • UCAML Study (H-26558)
    • This study uses umbilical cord stem cells following high dose chemotherapy to treat patients with myeloid hematological malignancies.